In this era of razor-thin margins, your hospital pharmacy can be a strategic contributor. Sentri7's evidence-based guidance and tools advance medication therapy to help your team maximize its contribution by improving clinical outcomes and pharmacy cost savings.
CMS has incorporated Antimicrobial Use and Resistance (AUR) reporting to the National Health and Safety Network (NHSN) as a required element under the Public Health reporting category within the Promoting Interoperability Program beginning in 2024.
To qualify for the Promoting Interoperability program credit, AUR reports must be submitted to the NHSN by a vendor—like Sentri7® Pharmacy AMS—certified for AUR reporting by the ONC and listed on the Certified Health IT Product List (CHPL).
As a validated provider, you can be confident your Antimicrobial Use and Antimicrobial Resistance data submitted by Sentri7 complies with the National Healthcare Safety Network (NHSN) protocols.
NHSN requires all production AU Summary Clinical Document Architecture (CDA) files to contain an SDS Validation ID, which the NHSN provides to each vendor after successful validation.
Sentri7 Pharmacy Surveillance: Additional add-on technology
Antimicrobial Stewardship
Interested in how Sentri7 Pharmacy can empower your pharmacy’s team to improve performance, optimize medication therapies, and improve patient outcomes?
To request a demo and speak with our expert team about Sentri7, please fill out the form.
